How Eli Lilly’s new GLP‑1 pill stacks up against Wegovy and other weight‑loss drugs

www.scientificamerican.com

How Eli Lilly’s new GLP‑1 pill stacks up against Wegovy and other weight‑loss drugs

www.scientificamerican.com

paywallMB to Scientific AmericanEnglish · 2 hours ago

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

www.scientificamerican.com

This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, resulted in an average of 27 pounds lost in 72 weeks

From Scientific American via this RSS feed

You must log in or # to comment.

Chat

Scientific American

scientificamerican

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !scientificamerican@ibbit.at

Community locked: only moderators can create posts. You can still comment on posts.

Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

27 users / day
54 users / week
199 users / month
536 users / 6 months
1 local subscriber
31 subscribers
1.48K Posts
158 Comments
Modlog